EFDA SOP Template (Free PDF Download)

EFDA SOP Template for Pharmaceutical Operations (Free PDF Download)

A complete standard operating procedure template for pharmaceutical operations under the Ethiopian Food and Drug Authority (EFDA) — written for manufacturers, importers, wholesalers and retail drug outlets. It covers licensing and premises, procurement, storage and cold chain, dispensing and sales, adverse drug reaction reporting, recalls, recordkeeping and the responsibilities table your inspectors expect to see. Adapt the bracketed fields to your operation and confirm current requirements with EFDA or a qualified Ethiopian regulatory consultant before implementation.

1. Purpose

To define the licensing, procurement, storage, dispensing, pharmacovigilance, recall and recordkeeping procedures required to operate a pharmaceutical facility in Ethiopia in line with the requirements of the Ethiopian Food and Drug Authority (EFDA).

2. Scope

Applies to [Facility Name], [Address, City], covering [manufacturing / importation / wholesale / retail pharmacy: select] operations, and all personnel involved in handling medicines and medical devices.

3. Regulatory Background

• The Ethiopian Food and Drug Authority (EFDA) regulates the licensing, importation, manufacture, distribution, storage and sale of medicines and medical devices in Ethiopia.
• Pharmaceutical facilities must hold a valid EFDA licence for their activity and operate under the supervision of a qualified and registered pharmacist.
• Good Manufacturing Practice (GMP), Good Distribution Practice (GDP) and Good Pharmacy Practice principles apply as EFDA requires for the relevant activity — confirm which standards apply to your facility type with EFDA.
• Only products registered or authorised by EFDA may be imported, manufactured or sold, subject to the exemptions EFDA currently allows — confirm the current position with EFDA.
• Suspected adverse drug reactions and defective or falsified products must be reported through EFDA's pharmacovigilance channels, and recall procedures must be in place before inspection.

4. Responsibilities

5. Procedure

5.1 Licensing and premises

1. Obtain and maintain a valid EFDA licence for [Facility Name] covering [manufacturing / importation / wholesale / retail: select]; display the current licence prominently on the premises.
2. Appoint a qualified responsible pharmacist, registered as required, to supervise all pharmaceutical operations.
3. Maintain premises that meet EFDA's structural, equipment and storage requirements for your activity type, including secure storage and temperature-controlled areas where required.
4. Renew licences and permits before expiry; track renewal dates in a compliance calendar.

5.2 Supplier verification and procurement

1. Source medicines only from EFDA-licensed suppliers and manufacturers; re-verify supplier licences annually.
2. Verify that every product is registered or authorised by EFDA before ordering — do not accept unregistered products unless a current EFDA exemption applies.
3. On receipt, check delivery documents against the order: product name, strength, quantity, batch number, manufacture and expiry dates.
4. Inspect physical condition and packaging integrity; quarantine anything damaged, suspect or falsified and report it to EFDA.

5.3 Storage and cold chain

1. Store all products according to label storage conditions; segregate quarantined, expired and recalled stock in clearly marked areas.
2. Maintain continuous temperature and humidity monitoring for controlled areas; review the logs [daily / weekly: select] and investigate any excursion.
3. Apply first-expiry-first-out (FEFO) rotation on every issue and dispatch.
4. Control access to scheduled and high-risk medicines; keep registers of all transactions.

5.4 Dispensing and sales (retail and dispensing facilities)

1. Dispense prescription-only medicines only against a valid prescription from an authorised prescriber.
2. Label every dispensed container with the patient name, medicine name and strength, directions for use, date of dispensing, dispenser name and facility name.
3. Counsel each patient on dosage, duration, storage and what to do if an adverse reaction occurs.
4. Record every dispensing transaction in the prescription register.

5.5 Pharmacovigilance

1. Train all dispensing staff to identify suspected adverse drug reactions (ADRs).
2. Report every suspected ADR to EFDA through the current reporting channel within the timeframe EFDA requires — confirm current timelines with EFDA.
3. Keep copies of all reports and follow-up correspondence in the pharmacovigilance file.

5.6 Complaints, defects and recall

1. Log every product complaint with the product name, batch, reporter and description.
2. Investigate defects; if a batch is defective or falsified is suspected, quarantine the stock immediately and notify EFDA.
3. On a recall decision, the responsible pharmacist initiates the recall without delay: identify and quarantine all affected batches, notify customers and patients, and account for all stock returned or destroyed.
4. Document the full recall: batches, quantities, notifications, returns and final disposition.

5.7 Recordkeeping and audit readiness

1. Keep prescription registers, procurement records, temperature logs, complaint files, recall files and ADR reports for the retention period EFDA requires — confirm the current period with EFDA.
2. Keep all SOPs, training records and licence copies in a controlled document file, with version numbers and approval signatures.
3. Conduct an internal audit against this SOP at least [annually / semi-annually: select] and record corrective actions.

6. Pro Tips

• Confirm requirements directly with EFDA. Licensing categories, timelines and reporting formats change — verify the current requirements with EFDA or a qualified Ethiopian regulatory consultant before your inspection, not from memory.
• Keep the licence calendar sacred. Assign one person to track licence, permit and registration expiry dates; operating on an expired licence is the fastest route to enforcement action.
• Train on ADR recognition. Most facilities under-report adverse reactions. Run a short annual training so every dispenser knows what counts and how to report it.
• Drill a mock recall. The first time you trace a batch should not be during a real recall — run one mock recall a year and keep the report.
• Treat quarantine as non-negotiable. Damaged, expired or suspect stock must be physically separated and clearly marked the moment it is identified — never left on the active shelves.

7. Frequently Asked Questions

Q1: What is EFDA? A: The Ethiopian Food and Drug Authority (EFDA) is the national regulator for medicines, medical devices, food safety and related products in Ethiopia. It licenses pharmaceutical facilities and registers the products they handle.

Q2: Which facilities need an EFDA licence? A: Manufacturers, importers, wholesalers and retail drug outlets each need the appropriate EFDA licence for their activity, operating under a qualified responsible pharmacist. Confirm which licence category applies to your facility with EFDA.

Q3: Can I sell unregistered medicines? A: Generally no — products must be registered or authorised by EFDA. Limited exemptions may exist; confirm the current position with EFDA before handling any unregistered product.

Q4: How should adverse drug reactions be reported? A: Through EFDA's pharmacovigilance reporting channel, within the timeframe EFDA requires. Train dispensing staff to recognise suspected reactions and keep copies of every report.

Q5: What records do inspectors check? A: Typically the current licence, prescription and controlled-medicine registers, procurement and supplier records, temperature logs, complaint and recall files, ADR reports, and staff training records — confirm current expectations with EFDA.

Q6: How often should this SOP be reviewed? A: Review it at least annually, or sooner whenever EFDA requirements, your product range or your processes change. Record each review with a version number, date and approver signature.